BellBrook

Transcreener UDP2 FI Assay

CHF 0.00
In stock
BBL-3019-A200 assaysCHF 532.00
BBL-3019-1K1000 assaysCHF 1'011.00
BBL-3019-10K10000 assaysCHF 5'152.00
BBL-3019-100K10 x 10000 assaysINQ
More Information
Product Details
Product Type Kit
Properties
Application Set Compound Screening
Crossreactivity All
Quantity

200 assays/96wells (BBL-3019-A)

1000 assays/384wells (BBL-3019-1K)

10000 assays/384wells (BBL-3019-10K)

10 x 10000 assays/384wells (BBL-3019-100K)

Note: The exact number of assays depends on enzyme reaction conditions.

Sensitivity Excellent data quality (Z’ ≥ 0.7) at low substrate conversion using 1µM UDP.
Range Accommodates UDP concentrations ranging from 1 μM to 100 μM.
Detection Type Fluorescence intensity
Kit Contains

UDP2 Antibody-IRDye® QC-1, UDP Alexa Fluor® 594 Tracer, Stop & Detect Buffer B, 10X, UDP

Note:  The plates are not included, please see manual for material not provided but necessary for assay.

Other Product Data

Click here for Complete Information from the Original Manufacturer
Our product description may differ slightly from the original manufacturers product datasheet.


Assay Features

Easy-to-Use (mix-and-read method).Simple homogenous biochemical assay. Direct detection of UDP eliminates laborious coupling steps. HTS Compatible with 96, 384, and 1536-well plates. Outstanding deck and signal stability. Excellent sensitivity.

Declaration Manufactured by BellBrook Labs.
Shipping and Handling
Shipping DRY ICE
Short Term Storage -20°C
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Documents
Manual Download PDF
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

The Transcreener® HTS Assay platform overcomes the need for time-consuming, one-off assay development for individual members within a group transfer enzyme family by utilizing a single set of assay reagents that detect an invariant product. The generic nature of the Transcreener® HTS Assay platform eliminates delays involved in assay development for new HTS targets, and greatly simplifies compound and inhibitor profiling across multiple target families. Transcreener assays have been validated with major HTS instruments to determine the optimal filters and settings for maximal assay performance. Application notes with all important details are available.

The Transcreener UDP2 assay is available in three fluorescent readouts, Fluorescence polarization (FP), Fluorescence Intensity (FI) and Time-resolved Forster-resonance-energy-transfer (TR-FRET), which provide a safe HTS-compatible alternative to cumbersome radioassay methods and are more sensitive and less subject to interference than other detection methods. 

The Transcreener® UDP2 FI Assay (Prod. No. BBL-3019) is a red, competitive fluorescence intensity (FI) assay. Because it is highly selective for UDP, the assay can be used with any enzyme that produces UDP, regardless of what other substrates are used. Examples include glycosyltransferases, galactosyltransferases, glucuronyltransferases, N-acetylglucosamyltransferases, N-acetylgalactosyltransferases, xylosyltransferases, and glycogen, cellulose, lactose, and hyaluronan synthases. The Transcreener® UDP2 Assay is a simple one step homogenous detection assay, and is extremely flexible with regard to UDP concentrations (1 to 100 μM). The assay provides excellent signal at low substrate conversion, with a Z’ ≥ 0.7 at low substrate conversion.

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.